PAM
RAPT

Panagora Asset Management’s RAPT Therapeutics RAPT Stock Holding History

Panagora Asset Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18
Closed -$5K – 2249
2021
Q2 		$5K Hold
18
– – ﹤0.01% 2495
2021
Q1 		$3K Hold
18
– – ﹤0.01% 2671
2020
Q4 		$3K Buy
+18
New +$3.91K ﹤0.01% 2582

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Panagora Asset Management's RAPT Position: Q3 2021 in Review

Panagora Asset Management sold out of RAPT Therapeutics (RAPT) in Q3 2021, closing a stake of 18 shares — an estimated $5K sold.

Panagora Asset Management first reported a position in RAPT in Q4 2020 and held it in 3 quarters. The position peaked at $5K in Q2 2021. 106 funds tracked by Wall St. Rank hold RAPT as of Q3 2021.

  • Panagora Asset Management reported no remaining RAPT Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 18 RAPT Therapeutics shares in Q3 2021, an estimated $5K.
  • Panagora Asset Management first reported a position in RAPT Therapeutics in Q4 2020 and held it in 3 quarters.
  • Panagora Asset Management's RAPT Therapeutics position peaked at $5K in Q2 2021.
  • 106 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.